 Fabienne Gally
Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fatty Acid-Binding Proteins | 6 | 2023 | 68 | 2.350 |
Why?
| | TRPM Cation Channels | 2 | 2018 | 77 | 1.110 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 3 | 2023 | 983 | 1.000 |
Why?
| | Smoke | 3 | 2017 | 139 | 0.940 |
Why?
| | PPAR gamma | 3 | 2022 | 183 | 0.900 |
Why?
| | Pneumonia, Mycoplasma | 4 | 2012 | 56 | 0.890 |
Why?
| | Neoplasm Proteins | 2 | 2019 | 422 | 0.830 |
Why?
| | Mycoplasma pneumoniae | 3 | 2012 | 56 | 0.820 |
Why?
| | Listeriosis | 2 | 2019 | 67 | 0.730 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2025 | 2063 | 0.710 |
Why?
| | Immunity, Innate | 6 | 2017 | 803 | 0.710 |
Why?
| | Listeria monocytogenes | 2 | 2019 | 123 | 0.700 |
Why?
| | Mucin-5B | 2 | 2022 | 214 | 0.650 |
Why?
| | Radiodermatitis | 1 | 2018 | 8 | 0.620 |
Why?
| | Macrophages | 3 | 2022 | 1484 | 0.580 |
Why?
| | Macrophages, Alveolar | 3 | 2021 | 389 | 0.560 |
Why?
| | Idiopathic Pulmonary Fibrosis | 2 | 2022 | 633 | 0.550 |
Why?
| | Inflammation | 5 | 2023 | 2737 | 0.540 |
Why?
| | Glycoproteins | 3 | 2021 | 338 | 0.540 |
Why?
| | JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 161 | 0.530 |
Why?
| | Cytokines | 4 | 2019 | 2013 | 0.510 |
Why?
| | Pneumonia | 3 | 2021 | 616 | 0.450 |
Why?
| | Lung | 8 | 2023 | 3927 | 0.430 |
Why?
| | Enhancer Elements, Genetic | 3 | 2025 | 176 | 0.410 |
Why?
| | Phosphoproteins | 2 | 2011 | 332 | 0.380 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2013 | 146 | 0.370 |
Why?
| | Bronchi | 1 | 2013 | 247 | 0.360 |
Why?
| | Epithelial Cells | 3 | 2017 | 1063 | 0.360 |
Why?
| | Down Syndrome | 1 | 2017 | 477 | 0.360 |
Why?
| | Mice, Knockout | 6 | 2021 | 2871 | 0.360 |
Why?
| | Pseudomonas aeruginosa | 2 | 2013 | 347 | 0.350 |
Why?
| | Mice | 17 | 2023 | 16915 | 0.350 |
Why?
| | Pseudomonas Infections | 1 | 2013 | 221 | 0.350 |
Why?
| | Down-Regulation | 1 | 2013 | 636 | 0.340 |
Why?
| | ADP-ribosyl Cyclase 1 | 1 | 2008 | 37 | 0.310 |
Why?
| | Respiratory Hypersensitivity | 1 | 2008 | 64 | 0.300 |
Why?
| | Mice, Inbred C57BL | 7 | 2018 | 5439 | 0.300 |
Why?
| | Toll-Like Receptor 2 | 3 | 2013 | 113 | 0.270 |
Why?
| | Influenza, Human | 1 | 2013 | 601 | 0.270 |
Why?
| | Oxidative Stress | 1 | 2013 | 1266 | 0.260 |
Why?
| | Cells, Cultured | 7 | 2019 | 4077 | 0.260 |
Why?
| | Bacterial Load | 2 | 2019 | 66 | 0.260 |
Why?
| | Animals | 18 | 2023 | 35309 | 0.250 |
Why?
| | Binding Sites | 2 | 2021 | 1250 | 0.250 |
Why?
| | Allergens | 1 | 2008 | 385 | 0.240 |
Why?
| | RNA, Messenger | 3 | 2019 | 2703 | 0.240 |
Why?
| | Gene Expression Regulation | 4 | 2025 | 2537 | 0.230 |
Why?
| | DNA-Binding Proteins | 1 | 2011 | 1446 | 0.220 |
Why?
| | Chemokine CX3CL1 | 1 | 2023 | 23 | 0.220 |
Why?
| | Transcription Factors | 1 | 2011 | 1647 | 0.210 |
Why?
| | Cell Line | 2 | 2021 | 2779 | 0.210 |
Why?
| | Receptors, Glucocorticoid | 2 | 2025 | 148 | 0.200 |
Why?
| | Superoxide Dismutase | 2 | 2015 | 342 | 0.190 |
Why?
| | Niemann-Pick Disease, Type A | 1 | 2021 | 4 | 0.180 |
Why?
| | Niemann-Pick Disease, Type B | 1 | 2021 | 4 | 0.180 |
Why?
| | Lysophospholipase | 1 | 2021 | 10 | 0.180 |
Why?
| | RNA | 2 | 2025 | 880 | 0.180 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2021 | 22 | 0.180 |
Why?
| | A549 Cells | 1 | 2021 | 59 | 0.180 |
Why?
| | NF-kappa B | 3 | 2019 | 665 | 0.180 |
Why?
| | Gain of Function Mutation | 1 | 2021 | 34 | 0.180 |
Why?
| | Lipopolysaccharides | 3 | 2023 | 877 | 0.180 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2023 | 396 | 0.180 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2021 | 53 | 0.180 |
Why?
| | Pulmonary Emphysema | 1 | 2023 | 275 | 0.170 |
Why?
| | Genetic Predisposition to Disease | 4 | 2025 | 2276 | 0.170 |
Why?
| | Chromatin | 2 | 2021 | 478 | 0.170 |
Why?
| | Humans | 18 | 2025 | 129266 | 0.170 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 947 | 0.170 |
Why?
| | Th2 Cells | 2 | 2012 | 171 | 0.160 |
Why?
| | Blotting, Western | 2 | 2013 | 1204 | 0.160 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 545 | 0.160 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 194 | 0.160 |
Why?
| | Respiratory Mucosa | 2 | 2012 | 307 | 0.160 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2018 | 132 | 0.150 |
Why?
| | Transcription, Genetic | 1 | 2025 | 1416 | 0.150 |
Why?
| | Alpha-Globulins | 1 | 2018 | 20 | 0.150 |
Why?
| | Models, Genetic | 1 | 2021 | 593 | 0.150 |
Why?
| | Mice, Transgenic | 5 | 2018 | 2117 | 0.140 |
Why?
| | RNA Polymerase II | 1 | 2021 | 317 | 0.140 |
Why?
| | Disease Models, Animal | 3 | 2021 | 4057 | 0.140 |
Why?
| | Mucociliary Clearance | 2 | 2018 | 42 | 0.140 |
Why?
| | Dexamethasone | 1 | 2019 | 350 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2017 | 132 | 0.130 |
Why?
| | Asthma | 2 | 2025 | 2229 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 361 | 0.130 |
Why?
| | Hyaluronic Acid | 1 | 2018 | 214 | 0.130 |
Why?
| | Disease Progression | 1 | 2023 | 2630 | 0.130 |
Why?
| | Epigenesis, Genetic | 1 | 2021 | 616 | 0.130 |
Why?
| | Inflammation Mediators | 1 | 2019 | 505 | 0.120 |
Why?
| | Cell Survival | 1 | 2019 | 1075 | 0.120 |
Why?
| | Acute Lung Injury | 1 | 2018 | 279 | 0.120 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 596 | 0.110 |
Why?
| | Protein Binding | 2 | 2018 | 2120 | 0.110 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2019 | 1202 | 0.110 |
Why?
| | Skin | 1 | 2018 | 726 | 0.110 |
Why?
| | Base Sequence | 1 | 2017 | 2146 | 0.110 |
Why?
| | Immunoprecipitation | 1 | 2013 | 157 | 0.100 |
Why?
| | Lipid Peroxidation | 1 | 2013 | 151 | 0.100 |
Why?
| | Immunoenzyme Techniques | 1 | 2013 | 214 | 0.100 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1204 | 0.100 |
Why?
| | Ovalbumin | 2 | 2012 | 178 | 0.100 |
Why?
| | Antioxidants | 2 | 2014 | 558 | 0.100 |
Why?
| | Physical Conditioning, Animal | 1 | 2015 | 229 | 0.100 |
Why?
| | Fluorescent Antibody Technique | 1 | 2013 | 376 | 0.100 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 328 | 0.100 |
Why?
| | Heat Shock Transcription Factors | 1 | 2011 | 19 | 0.100 |
Why?
| | Metalloporphyrins | 1 | 2012 | 101 | 0.100 |
Why?
| | Adaptive Immunity | 1 | 2013 | 161 | 0.090 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 316 | 0.090 |
Why?
| | Tobacco Products | 1 | 2013 | 110 | 0.090 |
Why?
| | Risk Factors | 2 | 2023 | 9745 | 0.090 |
Why?
| | Bronchoalveolar Lavage | 1 | 2011 | 92 | 0.090 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2011 | 69 | 0.090 |
Why?
| | Cartilage, Articular | 1 | 2015 | 292 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2013 | 333 | 0.090 |
Why?
| | Toll-Like Receptor 4 | 1 | 2013 | 263 | 0.090 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 833 | 0.090 |
Why?
| | Dendritic Cells | 1 | 2012 | 479 | 0.080 |
Why?
| | Chimera | 1 | 2008 | 59 | 0.080 |
Why?
| | Radiation Protection | 1 | 2008 | 36 | 0.070 |
Why?
| | Lead | 1 | 2008 | 56 | 0.070 |
Why?
| | Models, Animal | 1 | 2009 | 376 | 0.070 |
Why?
| | Antibody Formation | 1 | 2008 | 291 | 0.070 |
Why?
| | Bone Marrow | 1 | 2008 | 271 | 0.070 |
Why?
| | Male | 5 | 2025 | 63512 | 0.070 |
Why?
| | Immunoglobulin E | 1 | 2008 | 329 | 0.070 |
Why?
| | Gene Expression | 2 | 2022 | 1466 | 0.070 |
Why?
| | Immunization | 1 | 2008 | 411 | 0.060 |
Why?
| | Caenorhabditis elegans | 1 | 2009 | 290 | 0.060 |
Why?
| | Lymph Nodes | 1 | 2008 | 470 | 0.060 |
Why?
| | Receptors, Drug | 1 | 2004 | 13 | 0.060 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2025 | 49 | 0.060 |
Why?
| | Potassium Channels, Inwardly Rectifying | 1 | 2004 | 36 | 0.060 |
Why?
| | Immunoglobulin G | 1 | 2008 | 848 | 0.060 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2004 | 133 | 0.050 |
Why?
| | Potassium Channels | 1 | 2004 | 149 | 0.050 |
Why?
| | CX3C Chemokine Receptor 1 | 1 | 2023 | 19 | 0.050 |
Why?
| | Signal Transduction | 2 | 2019 | 4926 | 0.050 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2025 | 235 | 0.050 |
Why?
| | Endothelium | 1 | 2023 | 121 | 0.050 |
Why?
| | Hypertension, Pulmonary | 1 | 2014 | 1894 | 0.050 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 1247 | 0.050 |
Why?
| | alpha 1-Antitrypsin | 1 | 2023 | 107 | 0.050 |
Why?
| | Air Pollution | 1 | 2025 | 216 | 0.050 |
Why?
| | Wnt Signaling Pathway | 1 | 2023 | 170 | 0.050 |
Why?
| | Cell Communication | 1 | 2023 | 300 | 0.050 |
Why?
| | Ligands | 1 | 2023 | 621 | 0.050 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 2021 | 11 | 0.050 |
Why?
| | Th1-Th2 Balance | 1 | 2021 | 8 | 0.050 |
Why?
| | Chitinases | 1 | 2021 | 9 | 0.050 |
Why?
| | CD11 Antigens | 1 | 2021 | 30 | 0.050 |
Why?
| | Cell Size | 1 | 2021 | 87 | 0.050 |
Why?
| | CD11b Antigen | 1 | 2021 | 60 | 0.050 |
Why?
| | Lectins | 1 | 2021 | 48 | 0.040 |
Why?
| | Monocytes | 1 | 2023 | 551 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 578 | 0.040 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 352 | 0.040 |
Why?
| | Stem Cells | 1 | 2023 | 574 | 0.040 |
Why?
| | Phagocytosis | 1 | 2021 | 362 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 324 | 0.040 |
Why?
| | Female | 3 | 2025 | 68551 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2023 | 746 | 0.040 |
Why?
| | DNA Methylation | 1 | 2022 | 610 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2019 | 696 | 0.030 |
Why?
| | DNA | 1 | 2022 | 1396 | 0.030 |
Why?
| | Neutrophils | 1 | 2021 | 1207 | 0.030 |
Why?
| | Cohort Studies | 1 | 2025 | 5409 | 0.030 |
Why?
| | Sepharose | 1 | 2014 | 33 | 0.030 |
Why?
| | Aging | 1 | 2023 | 1774 | 0.030 |
Why?
| | Glycine | 1 | 2014 | 165 | 0.030 |
Why?
| | Arginine | 1 | 2014 | 265 | 0.030 |
Why?
| | Heparin | 1 | 2014 | 253 | 0.030 |
Why?
| | Doxycycline | 1 | 2012 | 59 | 0.030 |
Why?
| | Osteoarthritis | 1 | 2015 | 168 | 0.030 |
Why?
| | Running | 1 | 2015 | 223 | 0.020 |
Why?
| | Bone and Bones | 1 | 2015 | 295 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2015 | 639 | 0.020 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2014 | 644 | 0.020 |
Why?
| | Sequence Analysis, DNA | 1 | 2014 | 776 | 0.020 |
Why?
| | Knee Joint | 1 | 2015 | 372 | 0.020 |
Why?
| | Genotype | 1 | 2014 | 1835 | 0.020 |
Why?
| | Cotinine | 1 | 2009 | 75 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2012 | 1155 | 0.020 |
Why?
| | RNA Interference | 1 | 2009 | 450 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 6543 | 0.020 |
Why?
| | Nicotine | 1 | 2009 | 302 | 0.020 |
Why?
| | Sulfonylurea Receptors | 1 | 2004 | 5 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2012 | 2375 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 2004 | 149 | 0.010 |
Why?
| | Protein Structure, Secondary | 1 | 2004 | 340 | 0.010 |
Why?
| | Middle Aged | 1 | 2025 | 31090 | 0.010 |
Why?
| | Adult | 1 | 2025 | 35495 | 0.010 |
Why?
| | Models, Molecular | 1 | 2004 | 1487 | 0.010 |
Why?
|
|
Gally's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|